Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
48.94 USD | -1.77% | -4.45% | +13.76% |
Apr. 11 | Wells Fargo Raises Price Target on Ryan Specialty Group to $58 From $57, Keeps Overweight Rating | MT |
Mar. 04 | UBS Raises Ryan Specialty Price Target to $62 From $57, Maintains Buy Rating | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- For the past twelve months, EPS forecast has been revised upwards.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With an expected P/E ratio at 39.06 and 26.97 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is not the most generous with respect to shareholders' compensation.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Multiline Insurance & Brokers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.76% | 5.81B | - | ||
+4.10% | 51.16B | B- | ||
+4.04% | 25.66B | C+ | ||
+14.55% | 23.24B | C | ||
+26.59% | 9.56B | - | ||
-4.12% | 4.02B | B | ||
+1.30% | 1.99B | C+ | ||
+11.16% | 1.76B | C- | ||
-26.78% | 1.4B | C- | ||
+14.35% | 1.27B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- RYAN Stock
- Ratings Ryan Specialty Holdings, Inc.